Alliancebernstein L.P. Soleno Therapeutics Inc Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021
SELL
$0.97 - $1.32 $18,527 - $25,212
-19,100 Closed
0 $0
Q4 2020

Feb 08, 2021
SELL
$1.61 - $2.23 $5,957 - $8,251
-3,700 Reduced 16.23%
19,100 $37,000
Q3 2020

Nov 12, 2020
SELL
$1.71 - $2.51 $20,178 - $29,617
-11,800 Reduced 34.1%
22,800 $57,000
Q2 2020

Aug 13, 2020
BUY
$1.77 - $4.23 $61,242 - $146,358
34,600 New
34,600 $77,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $451M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email